Cargando…
Efficacy and safety of adding mizoribine to standard treatment in patients with immunoglobulin A nephropathy: A randomized controlled trial
BACKGROUND: Mizoribine (MZR) is an immunosuppressive drug used in Japan for treating patients with lupus nephritis and nephrotic syndrome and has been also reportedly effective in patients with immunoglobulin A (IgA) nephropathy. However, to date, few randomized control studies of MZR are performed...
Autores principales: | Hirai, Keiji, Ookawara, Susumu, Kitano, Taisuke, Miyazawa, Haruhisa, Ito, Kiyonori, Ueda, Yuichirou, Kaku, Yoshio, Hoshino, Taro, Mori, Honami, Yoshida, Izumi, Kubota, Kenji, Yamaji, Yasuyoshi, Takeda, Tetsuro, Nakamura, Yoshikazu, Tabei, Kaoru, Morishita, Yoshiyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Nephrology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491162/ https://www.ncbi.nlm.nih.gov/pubmed/28680823 http://dx.doi.org/10.23876/j.krcp.2017.36.2.159 |
Ejemplares similares
-
Approximation of Corrected Calcium Concentrations in Advanced Chronic Kidney Disease Patients with or without Dialysis Therapy
por: Kaku, Yoshio, et al.
Publicado: (2015) -
Effects and Safety of Linagliptin as an Add-on Therapy in Advanced-Stage Diabetic Nephropathy Patients Taking Renin–Angiotensin–Aldosterone System Blockers
por: Ueda, Yuichiro, et al.
Publicado: (2016) -
Factors associating with oxygenation of lower-limb muscle tissue in hemodialysis patients
por: Miyazawa, Haruhisa, et al.
Publicado: (2016) -
Changes in urinary potassium excretion in patients with chronic kidney disease
por: Ueda, Yuichiro, et al.
Publicado: (2016) -
A Higher Cardiothoracic Ratio Is Associated with 2-Year Mortality after Hemodialysis Initiation
por: Ito, Kiyonori, et al.
Publicado: (2015)